SEP-1 has moved beyond a quality reporting exercise. As performance tied to Value-Based Purchasing begins to materially impact hospital reimbursement, sepsis-related decisions increasingly carry meaningful financial, operational, and clinical consequences.
Many health systems continue to manage sepsis through a compliance-first lens, aiming to avoid penalties while balancing complex and sometimes competing operational priorities. These approaches can unintentionally increase length of stay, strain emergency department flow, limit inpatient capacity and frustrate clinicians, while introducing reimbursement risk that is not always visible in real time.
This webinar examines how those challenges are showing up across hospitals today and why long-standing sepsis strategies are being re-evaluated as payment realities evolve. Clinical leaders will unpack where organizations often misjudge their exposure, and how early decision - making at triage including emerging approaches that assess the patients' host response may influence outcomes well beyond SEP-1 checkboxes.
The discussion will also explore how lessons learned from SEP-1 performance are shaping how organizations prepare for what comes next in federal sepsis measurement.
Attendees will learn:
- Where compliance-first sepsis strategies create unintended system strain
- How early clinical decisions affect throughput and inpatient capacity
- The relationship between SEP-1 performance, outcomes and reimbursement risk
- What leaders should consider as Value-Based Purchasing stakes continue to rise
- How emerging approaches to early sepsis assessment, including host-response insights, is influencing sepsis strategy
-2.png?width=120&height=120&name=image%20(14)-2.png)